NASDAQ:TARA | Free Cash Flow | Protara Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$21.34M
2025-12-31-$16.95M$24,000.00-$16.97M
2025-03-31-$14.71M$44,000.00-$14.76M
2024-12-31-$9.31M$0.00-$9.31M
2024-03-31-$10.38M
2023-12-31-$8.7M$0.00-$8.7M
2023-03-31-$12.89M$6,000.00-$12.89M
2022-12-31-$5.03M$6,000.00-$5.03M
2022-03-31-$10.96M$11,000.00-$10.97M
2021-12-31-$6.91M$44,000.00-$6.95M
2021-03-31-$11.92M$290,000.00-$12.21M
2020-12-31-$6.77M$511,000.00-$7.28M
2020-03-31-$7.15M$247,000.00-$7.39M
2019-12-31-$1.09M$45,862.00-$1.13M
2019-03-31-$1.41M$27,113.00-$1.43M
2018-12-31-$4.31M$95,000.00-$4.41M
2018-03-31-$5.46M$9,000.00-$5.47M
2017-12-31-$5.7M$12,000.00-$5.71M
2017-03-31-$7.45M$6,000.00-$7.45M
2016-12-31-$5.58M$12,000.00-$5.59M
2016-03-31-$5.89M$8,000.00-$5.9M
2015-12-31-$5.19M$27,000.00-$5.21M
2015-03-31-$3.87M$5,000.00-$3.88M
2014-12-31-$2.05M$6,000.00-$2.06M-28.43%
2014-03-31-$1.56M
2013-12-31-$1.75M$9,000.00-$1.76M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$56.37M$94,000.00-$56.46M
2024-12-31-$35.81M$63,000.00-$35.87M
2023-12-31-$37.56M$45,000.00-$37.6M
2022-12-31-$26.46M$120,000.00-$26.58M
2021-12-31-$34.5M$596,000.00-$35.1M
2020-12-31-$23.41M$884,000.00-$24.29M
2019-12-31-$5.01M$475,000.00-$5.49M
2018-12-31-$23.23M$119,000.00-$23.35M
2017-12-31-$22.35M$35,000.00-$22.39M
2016-12-31-$23.69M$271,000.00-$23.96M
2015-12-31-$17.57M$198,000.00-$17.76M
2014-12-31-$9.99M$51,000.00-$10.04M
2013-12-31-$6.66M$10,000.00-$6.67M
2012-12-31-$8.23M$67,000.00-$8.3M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.